Lynda Charters Enoch started her early “eye life” at the Schepens Eye Research Institute, Boston, which ultimately culminated in her current position as an Editor of Ophthalmology Times.
Decreased cone densities may help detect and monitor multiple sclerosis
April 13th 2023Decreased cone density was a characteristic of the cases of multiple sclerosis (MS) that were evaluated. This finding may serve as a specific and sensitive method to detect and monitor the development and progression of MS.
Read More
Crystalline lens power: The primary driver of the refractive error in ROP eyes treated with laser
April 13th 2023The study compared eyes with retinopathy of prematurity (ROP) treated with laser to age-matched control eyes without ROP and found that the spherical equivalent was significantly more myopic in the eyes treated with laser.
Read More
ARVO 2023: Opportunities to enjoy social/networking events
April 13th 2023The 2023 Association for Research in Vision and Ophthalmology (ARVO) annual meeting promises to provide numerous opportunities to meet up with old friends and colleagues and forge relationships with new ones as well as enhance future research and practice endeavors.
Read More
ARVO 2023: Celebrating the beauty of diversity in science and nature
April 12th 2023The Association for Research in Vision and Ophthalmology (ARVO) 2023 annual meeting is convening in New Orleans from April 23 to 27 at the Ernest N. Morial Convention Center. The theme of the Annual Meeting speaks both to the mechanistic diversity in ocular disease in addition to the diversity of vision scientists who are from multiple backgrounds and perspectives.
Read More
COPHy 2023: New restorative therapies
March 24th 2023In a keynote lecture at the 14th Annual Congress on Controversies in Ophthalmology in Lisbon, Hendrik Scholl, MD, co-founder and director of the Institute of Molecular and Clinical Ophthalmology Basel, discussed its mission to unravel the mysteries of vision and human eye disease.
Read More
APAO 2023: Beveled tip probe added to arsenal for retinal detachment vitrectomy
February 24th 2023Yusuke Oshima, MD, PhD, in a presentation at the 38th Asia-Pacific Academy of Ophthalmology Congress, Kuala Lumpur, Malaysia, discussed the advantages of using a beveled-tip ultra-speed probe for complete vitreous shaving during retinal detachment vitrectomies.
Read More
APAO 2023: Step therapy from Bevacizumab to Aflibercept for DME
February 24th 2023Voraporn Chaikitmongkol, MD, discussed step therapy and reported the results of a major study, the Diabetic Retinopathy Clinical Research (DRCR) Protocol AC, at the 38th Asia-Pacific Academy of Ophthalmology Congress, in Kuala Lumpur, Malaysia.
Read More
APAO 2023: Looking at anatomic outcomes in matched comparison: TENAYA and LUCERNE data
February 23rd 2023Greater anatomic improvements (central subfield thickness reduction, proportion with absence of subretinal fluid and intraretinal fluid) were seen with faricimab versus aflibercept during the matched dosing period (week 4, week 8, and week 12).
Read More
FDA: Apellis' pegcetacoplan approved for the treatment of geographic atrophy
February 17th 2023Apellis has received FDA approval for intravitreal pegcetacoplan (SYFOVRE) to treat geographic atrophy secondary to AMD. This news follows the submission of the 24-month phase 3 data in November 2022.
Read More
Networking and social activities abound for APAO delegates
February 15th 2023The agenda includes the Opening Ceremony, Women in Ophthalmology Luncheon, and Young Ophthalmologists’ Night, and that's only a sampling. The results of the APAO-Asia-Pacific Ocular Imaging Competition will also be announced.
Read More
Angiogenesis 2023: The mystery of geographic atrophy shifts with data
February 10th 2023In a presentation at the 2023 Angiogenesis, Exudation, and Degeneration program, Usha Chakravarthy, PhD, FRCOphth, CBE, presented data from the trial of lampalizumab, which is peeling back some of the mystery shrouding geographic atrophy.
Read More
Angiogenesis 2023: Using ophthalmic artery angioplasty to treat AMD
February 10th 2023In a presentation at Bascom Palmer’s 2023 Angiogenesis, Exudation, and Degeneration conference in Miami, Pedro Lylyk, MD, said ophthalmic artery angioplasty could prove to be a treatment option for patients diagnosed with age-related macular degeneration.
Read More
Angiogenesis 2023: Comparing GA phenotypes and progression rates in Asians, non-Asians
February 10th 2023A study conducted by Gemmy Cheung, MBBS, FRCOphth and colleagues shows geographic atrophy (GA) lesion phenotypes, associated features, and growth rates differ between Asians and non-Asians.
Read More